Our new review in @TrendsinPharma!
Perianal fistulizing Crohn’s disease: from emerging molecular insights to novel therapies and precision treatment.
Can multiomics help guide therapeutic decisions?
doi.org/10.1016/j.tips.2026.…
#IBD #CrohnsDisease
19
USBIOS IG-IBD: 462 adults with stable Crohn’s disease, 18 centres. Six-month clinical success: 92.2% after switching to an ustekinumab biosimilar vs 92.7% on reference treatment—meeting the noninferiority criterion. cghjournal.org/article/S1542… #IBD #Biosimilars
11
Real-World Safety and Herpes Zoster Outcomes After Recombinant Zoster Vaccination in Inflammatory Bowel Disease mdpi.com/3970718 #mdpijcm via @JCM_MDPI
Histological healing in inflammatory bowel disease (#IBD #colitis #Crohn): is it only a matter of neutrophils? mdpi.com/3751674 #mdpidiagnostics via @diagnostic_mdpi
23
Can we select #advanced #therapies in #IBD based on the patient’s #molecular profile?cell.com/trends/molecular-me…
16
Relapse Rates and Predictors for Relapse in Ulcerative Colitis and Crohn’s Disease Patients After Discontinuation of Vedolizumab or Ustekinumab: The REVEUS Study mdpi.com/3214784 #mdpijcm via @JCM_MDPI
29
Type 2 #Diabetes Mellitus in #Inflammatory Bowel Disease Patients: A Case–Control Study Through a Long Follow-Up Period mdpi.com/3112104 #mdpijcm via @JCM_MDPI
1
15
Associations Between Polymorphisms of #Genes Related to #VitaminD Pathway and the Response to #Vedolizumab and #Ustekinumab in #InflammatoryBowelDisease mdpi.com/3066254 #mdpijcm via @JCM_MDPI
23
Davide G. Ribaldone retweeted
💥 New Podcast Episode
@Sciencythoughts interviewed @CeliaEscuderoHe on their molecular study which dives into the pathogenesis of lymphocytic colitis
🔗 pod.link/1555253769/episode/…
🔗 onlinelibrary.wiley.com/doi/…
Davide G. Ribaldone retweeted
🩸🩸Dieulafoy's lesion 🩸🩸
✅️ first described in 1️⃣8️⃣9️⃣7️⃣
✅️ this case treated by #APC & placement of #endoclips
📕 only in @UEGJournal 😉
👇👇👇
is.gd/zXflSp ❗️
🟢 @my_ueg
🟣 @WileyHealth
🔵 @ESGE_news
🔴 @stevenbollipo @drkeithsiau
⚪️ #GITwitter – at Miami, FL
📢❓️What's the Dx❓️
✅️ 27 y/o female w recurrent upper GI #bleeding
➡️ After common #bile duct resection due to cyst 20 y ago
➡️ hepaticojejunostomy reached by #enteroscopy
🟢 @my_ueg
🟣 @WileyHealth
🔵 @ESGE_news
@DrBloodandGuts @stevenbollipo & @drkeithsiau
#GITwitter
Davide G. Ribaldone retweeted
📢❓️What's the Dx❓️
✅️ 27 y/o female w recurrent upper GI #bleeding
➡️ After common #bile duct resection due to cyst 20 y ago
➡️ hepaticojejunostomy reached by #enteroscopy
🟢 @my_ueg
🟣 @WileyHealth
🔵 @ESGE_news
@DrBloodandGuts @stevenbollipo & @drkeithsiau
#GITwitter – at Brno, Czech Republic
Davide G. Ribaldone retweeted
💥New Podcast Edition
@Sciencythoughts interviewed Mathias Brugel from France on their study investigating the association of organochlorine pesticides and pancreatic adenocarcinoma which show a positive correlation.
pod.link/1555253769
🔗 to 📄 doi.org/10.1002/ueg2.12602
Davide G. Ribaldone retweeted
📢 What is the #diagnosis for this #esophageal lesion❓️
1️⃣2️⃣ mm flat lesion (15 cm from the dental arch)
💥NBI w/ 🔎:
Intrapapillary capillary loops unusually dilated and thickened
🔵 @ESGE_news 🔵
@stevenbollipo @drkeithsiau @KralJan @OncoAlert
#GITwitter 🔴
#endoscopy – at Olomouc, Czech Republic
Davide G. Ribaldone retweeted
✴️ First comprehensive study on pancreatitis in ages 0-19 (1990-2019)
•Incidence/prevalence rising
•Mortality/DALY rates declining
•Prevention critical
doi.org/10.1002/ueg2.12672
Davide G. Ribaldone retweeted
🆕 Episode
✴️ @Sciencythoughts & @htkani interviewed Asa Frandemark on her best paper award winning study investigating work productivity & activity impairment in DGBI disorders which evaluated data from the Rome Foundation Global Epidemiology Study
🔗 pod.link/1555253769/episode/…
#chatgpt4o when i try lo login to my android app I get this "code:628bad21-2aa5-456b-b4a
7-00b87ea7f052,service 401
8c63704e8a84bb23-MXP"
11
Davide G. Ribaldone retweeted
🆕 Editorial in UEGJ
- Assess post-operative bowel symptoms.
- Perform physical exams, including abdominal and anorectal.
- Conduct stool testing for diagnosis.
- Consider dietary adjustments and lifestyle changes.
- Use medications for managing symptoms.
doi.org/10.1002/ueg2.12659













